Stoke Therapeutics(STOK.US)

Event Tracking

Mar17

Stoke Therapeutics released FY2025 annual earnings on March 16 (EST), actual revenue USD 184.42 M (forecast USD 188.8 M), actual EPS USD -0.1162 (forecast USD 0.1216)

03:00

Stoke Therapeutics released FY2025 Q4 earnings on March 16 (EST), actual revenue USD 1.402 M (forecast USD 5.825 M), actual EPS USD -0.9384 (forecast USD -0.7441)

03:00

Jan11

Stoke Therapeutics Accelerates Patient Enrollment for Phase 3 Study of Zorevunersen with Biogen

19:00

Jan5

Chardan Capital Raises Stoke Therapeutics Target Price

13:39

Dec17

HC Wainwright Raises Stoke Therapeutics EPS Forecast

13:46

Dec10

Stoke Therapeutics Inc. Director Sells Company Common Stock